Overview

To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis B

Status:
Unknown status

Trial end date:
2019-05-01

Target enrollment:

Participant gender:

Summary

To assess whether PEG-INF (Peglyated - interferon) Add-on therapy in patients of CHB who have achieved a maintained viral suppression (HBV DNA PCR( polymerase chain reaction) <200 for last 3-6 month) with NA's can result in increased rate of HBV infection eradication (HbsAg is undetectable by serological blood testing with or without seroconversion to HBs antibody).

Phase:

Phase 4

Details

Lead Sponsor:

King Abdullah International Medical Research Center

Collaborator:

Hoffmann-La Roche

Treatments:

Interferons